Recent developments in neuroscience can help inform clinicians' understanding of cognition, emotion, behavioral regulation, and social interactions—all critical aspects of people's lives that are dramatically affected in psychiatric disorders. Some areas of neuroscience are of particular relevance to clinicians because they help further the understanding of patients and can lead to the development of novel therapeutics.
Some of my work include the neurobiology of eating disorders, depression and OCD.
While cognitive behavioral therapy (CBT) is an effective treatment for major depressive disorder, only up to 45% of depressed patients will respond to it. At present, there is no clinically viable neuroimaging predictor of CBT response. To obtain mechanistically meaningful fMRI predictors of CBT response, we capitalize on pretreatment neural activity encoding a weighted prediction error, which is implicated in the acquisition and processing of feedback information during probabilist learning.